Chip Wilson sent his first shareholder letter Friday, marking the transition from public criticism to direct institutional contact in his effort to replace directors at Lululemon Athletica. The founder now controls roughly 8.4% of outstanding shares through his investment vehicle and has moved past regulatory filings into active persuasion of the top 40 institutional holders who control 62% of the float.
The letter arrived six weeks ahead of Lululemon's preliminary proxy filing, due in mid-March under SEC rules for a late-May annual meeting. Wilson's team is working the calendar: reaching asset managers before management's narrative sets in the official proxy materials, and before Glass Lewis and ISS publish their voting recommendations in early May. The $45 billion market cap makes this a top-20 Russell 1000 holding for several large-cap growth managers, who now face a binary choice between a founder with product credibility and a board that delivered 31% revenue growth over three years but saw the stock fall 46% from its 2021 peak.
This is not about Wilson wanting his company back. He resigned from the board in 2015 and sold his majority stake in stages between 2014 and 2020. The current fight centers on execution: Wilson argues the brand has lost differentiation in product and expanded too slowly in men's and international markets while competitors took share. The board's counter-narrative emphasizes margin expansion and disciplined growth, but the stock has underperformed Nike, On Running, and private comps like Alo Yoga over the past 24 months.
The structure of this fight matters for other founder-董事 disputes in consumer. Wilson is not seeking control or a CEO change. He is nominating a minority slate—likely two to three directors to an 11-person board—focused on product and brand strategy. This makes the fight easier to sell to institutions who dislike full-board challenges but will consider targeted refreshment. If Wilson wins even two seats, he forces the board into a negotiation on brand positioning and capital allocation without triggering the governance alarms that sink most activist campaigns at large-cap companies.
Allocators should watch three specific points. First, whether Fidelity and Vanguard—who together hold 18%—publicly state a position before the proxy deadline. Second, whether Wilson names his director candidates by early March, giving institutions time to vet them before ISS recommendations. Third, whether Lululemon's board offers a negotiated settlement: one Wilson-approved director in exchange for standstill through 2026.
The company reports Q4 earnings on March 27. If comparable-store sales disappoint or guidance comes in soft, Wilson's narrative gains weight. If the quarter beats and management raises the full-year outlook, institutions will find it easier to vote with the board. The stock closed Friday at $372, up 4% from the day Wilson filed his Schedule 13D in January but still 22% below where it traded when the current CEO took over in 2018.